RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Results from the EURAMOS-1 Trial
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 6
SP 25
OP 25
DO 10.1177/155989771306021
UL http://mdc.sagepub.com/content/13/6/25.abstract
AB Results from the Combination Therapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma trial [EURAMOS-1; NCT00134030; J Clin Oncol 2013 (suppl; abstr LBA10504)] show that maintenance therapy with pegylated interferon a-2b (PEG IFN-a-2b) after surgery and chemotherapy does not improve event-free survival in patients with high-grade osteosarcoma and good response to preoperative methotrexate, doxorubicin, and cisplatin (regimen collectively called MAP).